Search results for: biosciences antibodies

In order to rapidly bring candidate vaccines to the public and put a stop to widespread illness and death, multiple vaccine candidates are undergoing parallel development at unprecedented speed.The Helminth Immunology Section requires specific antibodies to continue research on potential vaccine candidate for COVID-19.Please see attachment for list of BD Biosciences antibodies.Place of Performance: Leidos Biomedical Research, 1050 Boyles St, Frederick

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Becton, Dickinson & Co., One Becton Drive Franklin Lakes, NJ 07417 to continue to collect cellular immunity data needed for continuous access to flow cytometry reagents, including antibodies and staining, permeabilization, fixation, and blocking reagents.

This acquisition will be awarded pursuant to the authority in FAR Part 13 and is exempt from the requirements of FAR Part 6.The PhenoCycler chemistry developed by Akoya Biosciences is an automated workflow which utilizes antibodies labeled with specific oligonucleotide tags (barcodes).

The requirement is being competed full and open competition, without a small business set-aside.The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for Brand Name, BD Biosciences Antibodies, as listed in the attached Bill of Materials (BOM). See attachmentsPlace of Performance: NIH, 9000 Rockville Pike, Bldg.: 10 CRC, Bethesda, MD 20852, United States.

PRE-CLINICAL ASSESSMENT OF MONOCLONAL ANTIBODIES AND OTHER PROMISING VACCINES/AGENTS Solicitation ID/Procurement Identifier: N02CO7240681 Ultimate Completion Date: Sun Sep 29 17:00:00 GMT 2024

CONTINUATION SHEET REFERENCE NO. OF DOCUMENT BEING CONTINUED: CONTINUED ON NEXT PAGE PAGE 5 OF 30 PAGES SPE7L3-23-T-451P SECTION A administrative burden for either party involved when making an award. This does not apply to Auto IDC. If you anticipate quoting on a solicitation after the closing date, please submit a DIBBS quote with a bid type of “No Bid” and place an anticipated quote date or the reason you are not willing to quote. This does not prevent you from submitting an actual quote on DIBBS at a later date. It will overlay your previous no quote. This informs buyers of your intention to quote and prevents multiple calls for updates and cancelling of requirements assumed to be non-procurable due to no quotes/sources. The submission ...

The Medical Readiness Contracting Office – Pacific intends to issue a bulk-funded BPA call to Abbott Laboratories Inc. for Clinical Chemistry and Immunoassay reagents for September 2023 for Tripler Army Medical Center, Hawaii. The statutory authority permitting this award without providing full and open competition is FAR 13.106-1(b)(1)(i), which authorizes the Government to award contracts when the circumstances of the contract action deem only one reasonably available and no other suppliers or services will satisfy agency requirements. This announcement fulfills the synopsis requirement under FAR 5.201 and 5.203. This Notice of Intent is not a request for competitive quotes. Information received in response to this notice will be consider...